MOREDUN SCIENTIFIC LIMITED

Their core work

Moredun Scientific Limited is the commercial arm of the Moredun Research Institute, one of Scotland's foremost animal health research centres, translating veterinary science into practical products and expertise. Their work spans livestock disease control — from parasite vaccines to natural bioactive compounds that reduce antibiotic dependency in farm animals. They contribute specialist knowledge in natural antimicrobials (particularly polyphenol-rich plant extracts), reproductive technologies for livestock (sperm extenders), and udder health treatments for dairy cattle. As a private SME tightly coupled to an established research institute, they bridge academic animal science and commercially applicable veterinary solutions.

What they specialise in

How they've shifted over time

In the first half of their H2020 engagement (Paragone, 2015–2019), Moredun Scientific contributed to conventional biological approaches — vaccine development against helminth and protozoan parasites in sheep and cattle, the kind of science the Moredun Research Institute has pursued for decades. By the second half (NeoGiANT, 2021–2026), their recorded focus had shifted decisively toward plant-derived bioactive compounds: polyphenols and grape extracts as natural antimicrobials, antioxidants, and mastitis treatments. This shift mirrors a broader EU and UK policy pressure to reduce veterinary antibiotic use, and suggests the organisation is actively repositioning its commercial offer around the antibiotic-alternatives market.

They are moving from vaccine-centric parasitology toward plant-based bioactive solutions for infection control and reproductive performance — a commercially timely pivot given EU restrictions on veterinary antibiotic use.

How they like to work

Moredun Scientific operates exclusively as a third-party contributor rather than a formal participant or coordinator, meaning they are brought into consortia to supply specific specialist capabilities — biological assays, proprietary animal models, veterinary expertise, or product formulation know-how — rather than to lead scientific programmes. Despite this limited formal role, their two projects collectively involved 40 unique partners across 13 countries, indicating that major European consortia actively seek their input. This pattern suggests a highly specialist, in-demand niche role rather than a generalist partnership model.

With 40 unique consortium partners across 13 countries from only two projects, Moredun Scientific has unusually broad network reach for its size. Their collaborations span multiple European countries and likely include academic institutions, veterinary organisations, and agri-food industry partners given the livestock health focus.

What sets them apart

Moredun Scientific is rare in being a private SME with direct institutional ties to a dedicated animal health research institute (Moredun Research Institute, Edinburgh), giving it credibility and laboratory infrastructure that pure commercial companies lack. Their combination of classic veterinary immunology (parasite vaccines) and emerging natural antimicrobial science makes them a credible bridge partner for both traditional animal pharma consortia and newer agri-food innovation projects. For any consortium needing validated animal models, veterinary expertise, or antibiotic-alternative formulation testing for livestock, they represent a niche that few UK SMEs can fill.

Highlights from their portfolio

• NeoGiANT
  Runs to 2026 and covers three distinct application areas — antimicrobial feed, mastitis treatment, and reproductive technology — making it their most commercially multi-dimensional project to date.
• Paragone
  A long-running vaccine development project (2015–2019) that showcases Moredun's foundational strength in animal parasitology and their value as a specialist contributor to large biological research consortia.